|
TIPARP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.61690000002979E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.161900E-04 |
| Normal-vs-Stage2 |
2.645600E-01 |
| Normal-vs-Stage3 |
1.484430E-02 |
| Normal-vs-Stage4 |
3.770200E-02 |
| Stage1-vs-Stage2 |
5.142500E-03 |
| Stage1-vs-Stage3 |
8.964600E-01 |
| Stage1-vs-Stage4 |
3.038600E-01 |
| Stage2-vs-Stage3 |
5.912500E-02 |
| Stage2-vs-Stage4 |
1.727850E-01 |
| Stage3-vs-Stage4 |
4.801000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22359999999533E-05 |
| Normal-vs-AfricanAmerican |
2.253800E-02 |
| Normal-vs-Asian |
6.961000E-01 |
| Caucasian-vs-AfricanAmerican |
8.157600E-01 |
| Caucasian-vs-Asian |
8.982500E-02 |
| AfricanAmerican-vs-Asian |
1.834570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.386760E-04 |
| Normal-vs-Female |
3.204900E-03 |
| Male-vs-Female |
6.533800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.295700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.144500E-03 |
| Normal-vs-Age(61-80Yrs) |
6.221400E-04 |
| Normal-vs-Age(81-100Yrs) |
2.131000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.947800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.792200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.135800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.186800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.496400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.523400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.662100E-02 |
| Normal-vs-Grade 2 |
8.41839999999872E-05 |
| Normal-vs-Grade 3 |
1.197870E-02 |
| Normal-vs-Grade 4 |
9.119700E-02 |
| Grade 1-vs-Grade 2 |
9.253400E-01 |
| Grade 1-vs-Grade 3 |
7.298800E-01 |
| Grade 1-vs-Grade 4 |
5.061800E-01 |
| Grade 2-vs-Grade 3 |
5.823400E-01 |
| Grade 2-vs-Grade 4 |
3.967000E-01 |
| Grade 3-vs-Grade 4 |
7.009400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.364900E-03 |
| Normal-vs-ccB subtype |
1.000740E-03 |
| ccA subtype-vs-ccB subtype |
2.860600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.595600E-04 |
| Normal-vs-N1 |
3.228400E-01 |
| N0-vs-N1 |
4.625200E-01 |
|
|
